Skip to main content
. 2022 May 3;107(8):e3343–e3352. doi: 10.1210/clinem/dgac228

Table 2.

PIPs from Bayesian kernel machine regression modelsa of chemical mixtures and total body less head aBMD Z-scores in 12- to 19-year-old males (n = 453) and females (n = 395), 2011-2016 NHANES

Biomarker groups Group PIP Individual biomarkers Individual PIP
Males Serum PFAS 0.65 PFOA 0.76
PFOS 0.12
PFDA 0.03
PFHxS 0.06
PFNA 0.03
High-molecular-weight urinary phthalate biomarkers 0.79 ∑DEHPb 0.65
MBzP 0.22
MCOP 0.02
MCNP 0.06
MCPP 0.05
Low-molecular-weight urinary phthalate biomarkers 0.77 MBP 0.39
MiBP 0.58
MEP 0.03
Females Serum PFAS 0.33 PFOA 0.26
PFOS 0.10
PFDA 0.17
PFHxS 0.23
PFNA 0.24
High-molecular-weight urinary phthalate biomarkers 0.26 ∑DEHPb 0.19
MCOP 0.23
MCPP 0.23
MBzP 0.19
MCNP 0.16
Low-molecular-weight urinary phthalate biomarkers 0.36 MBP 0.28
MiBP 0.51
MEP 0.21

Abbreviations: aBMD, areal bone mineral density; BKMR, Bayesian kernel machine regression; DEHP, di(2-ethylhexyl)phthalate; MBzP, mono-benzyl phthalate; MCNP, mono(carboxynonyl) phthalate; MCOP, mono(carboxyoctyl) phthalate; MCPP, mono-(3-carboxypropyl) phthalate; MEP, mono-ethyl phthalate; MIBP, mono-isobutyl phthalate; NHANES, National Health and Nutrition Examination Survey; PFDA, perfluorodecanoate; PFHxS, perfluorohexane sulfonate; PFNA, perfluorononanoate; PFOA, perfluorooctanoate; PFOS, perfluorooctane sulfonate; MBP, mono-n-butyl phthalate; PIP, posterior inclusion probability.

aPIPs indicate the relative contribution of individual or group biomarkers to the overall fit of the BKMR model. Models are adjusted for age, race/ethnicity, physical activity, indoor smoking by a household member, urinary creatinine concentrations, NHANES weights, and NHANES cycle.

bMolar sum of mono (2-ethylhexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl) phthalate, mono(2-ethyl-5-oxohexyl) phthalate, and mono(2-ethyl-5-carboxypentyl) phthalate.